Species
|
Resource
|
RRC ID
|
Title
|
Journal
|
Published
|
Link
|
Human and Animal Cells
|
TT1TKB(RCB1185)
|
81925
|
Targeting ALDH1A1 to enhance the efficacy of KRAS-targeted therapy through ferroptosis.
|
Redox Biol |
2024-11-1 |
Pubmed
Full text
|
Human and Animal Cells
,
DNA material
|
ATN-1(RCB1440)
,
CS-RfA-EVBsd (RDB06090)
,
pENTR4-H1 (RDB04395)
,
CSII-EF-MCS-IRES2-Venus (RDB04384)
,
pCMV-VSV-G-RSV-Rev (RDB04393)
,
pCAG-HIVgp (RDB04394)
|
78274
|
Mechanisms of action and resistance in histone methylation-targeted therapy.
|
Nature |
2024-2-21 |
Pubmed
Full text
|
Human and Animal Cells
|
U251(RCB0461)
|
77544
|
Synthesis and anticancer activity of new 1-[(5 or 6-substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives.
|
Bioorg Med Chem |
2010-11-15 |
Pubmed
Full text
|
Human and Animal Cells
|
MOLT-4(RCB0206)
,
SKW-3(RCB1168)
|
77504
|
Drug resistance to nelarabine in leukemia cell lines might be caused by reduced expression of deoxycytidine kinase through epigenetic mechanisms.
|
Cancer Chemother Pharmacol |
2022-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HL60(RCB0041)
|
77166
|
Importance of inducible multidrug resistance 1 expression in HL-60 cells resistant to gemtuzumab ozogamicin.
|
Leuk Lymphoma |
2012-7-1 |
Pubmed
Full text
|
Human and Animal Cells
|
Lu-165(RCB1184)
|
72489
|
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade.
|
Nat Commun |
2021-7-14 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-3(RCB2145)
|
72482
|
Pleiotropic effects of probenecid on three-dimensional cultures of prostate cancer cells.
|
Life Sci |
2021-8-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HuH-7(RCB1366)
|
72236
|
The BAFF/NFκB axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts.
|
Cancer Sci |
2021-9-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HSC-2(RCB1945)
,
HSC-3(RCB1975)
,
HSC-4(RCB1902)
,
SAS(RCB1974)
|
69742
|
Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
|
Cancer Sci |
2022-2-1 |
Pubmed
Full text
|
Human and Animal Cells
|
OS-RC-2(RCB0735)
|
69471
|
Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice.
|
Cell Mol Gastroenterol Hepatol |
2021-1-1 |
Pubmed
Full text
|
DNA material
|
pCMV-VSV-G-RSV-Rev (RDB04393)
,
pCAG-HIVgp (RDB04394)
|
67736
|
Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.
|
Oncogene |
2019-4-1 |
Pubmed
Full text
|
Human and Animal Cells
|
DT40(RCB1464)
|
67556
|
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation.
|
Blood |
2015-7-2 |
Pubmed
Full text
|
Human and Animal Cells
|
MCF7(RCB1904)
|
67529
|
Sesquiterpenes with TRAIL-resistance overcoming activity from Xanthium strumarium.
|
Bioorg Med Chem |
2015-8-1 |
Pubmed
Full text
|
Human and Animal Cells
|
A549(RCB0098)
,
LC-2/ad(RCB0440)
|
67405
|
Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.
|
Mol Cancer Ther |
2015-11-1 |
Pubmed
Full text
|
Human and Animal Cells
|
CW-2(RCB0778)
|
67347
|
Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity.
|
Cancer Cell |
2021-8-9 |
Pubmed
Full text
|
Human and Animal Cells
|
Ba/F3
|
66042
|
Mechanisms of Resistance to NTRK Inhibitors and Therapeutic Strategies in NTRK1-Rearranged Cancers.
|
Mol Cancer Ther |
2017-10-1 |
Pubmed
Full text
|
Human and Animal Cells
|
JHOS-2(RCB1521)
,
JHOC-5(RCB1520)
|
65946
|
CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.
|
PLoS One |
2021-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
65151
|
Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14-mutant Non-small Cell Lung Cancer.
|
Clin Cancer Res |
2019-2-15 |
Pubmed
Full text
|
Human and Animal Cells
|
NALM-6(RCB1933)
,
PK45H(RCB1973)
,
LC-2/ad(RCB0440)
|
65073
|
Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease.
|
Sci Rep |
2017-9-6 |
Pubmed
Full text
|
Human and Animal Cells
|
Sa3(RCB0980)
|
65070
|
Mefenamic acid enhances anticancer drug sensitivity via inhibition of aldo-keto reductase 1C enzyme activity.
|
Oncol Rep |
2017-4-1 |
Pubmed
Full text
|